Search Results - "FRIESEN, Richard W"
-
1
Microsomal Prostaglandin E2 Synthase-1 (mPGES-1): A Novel Anti-Inflammatory Therapeutic Target
Published in Journal of medicinal chemistry (24-07-2008)Get full text
Journal Article -
2
MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation
Published in The Journal of pharmacology and experimental therapeutics (01-09-2008)“…Microsomal prostaglandin E synthase-1 (mPGES-1) is a terminal prostaglandin E(2) (PGE(2)) synthase in the cyclooxygenase pathway. Inhibitors of mPGES-1 may…”
Get more information
Journal Article -
3
Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886
Published in Bioorganic & medicinal chemistry letters (15-07-2005)“…A series of potent and selective inhibitors of the inducible microsomal PGE2 synthase (mPGES-1) has been developed based on the indole FLAP inhibitor MK-886…”
Get full text
Journal Article -
4
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors
Published in Bioorganic & medicinal chemistry letters (15-10-2009)“…Phenanthrene imidazoles 26 and 44 have been identified as novel potent, selective, and orally active mPGES-1 inhibitors. Phenanthrene imidazoles 26 and 44 have…”
Get full text
Journal Article -
5
The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor
Published in ACS medicinal chemistry letters (08-07-2010)“…The discovery of novel and selective inhibitors of human 5-lipoxygenase (5-LO) is described. These compounds are potent, orally bioavailable, and active at…”
Get full text
Journal Article -
6
Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors
Published in The Journal of pharmacology and experimental therapeutics (01-08-2005)“…The diseases of cystic fibrosis, chronic obstructive pulmonary disease (COPD), and chronic bronchitis are characterized by mucus-congested and inflamed…”
Get more information
Journal Article -
7
Substituted coumarins as potent 5-lipoxygenase inhibitors
Published in Bioorganic & medicinal chemistry letters (01-05-2006)“…A novel series of substituted coumarin derivatives has been synthesized. SAR studies in this series led to the identification of inhibitor 1. Leukotriene…”
Get full text
Journal Article -
8
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors
Published in Bioorganic & medicinal chemistry letters (15-12-2007)“…Phenanthrene imidazole 3 has been identified as a novel potent, selective, and orally active mPGES-1 inhibitor. Phenanthrene imidazole 3 (MF63) has been…”
Get full text
Journal Article -
9
On the controlled oxidative coupling of glycals: a new strategy for the rapid assembly of oligosaccharides
Published in Journal of the American Chemical Society (01-08-1989)Get full text
Journal Article -
10
Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment
Published in Bioorganic & medicinal chemistry letters (15-11-2010)“…The structure–activity relationship of a novel series of 8-biarylnaphthyridinones acting as type 4 phosphodiesterase (PDE4) inhibitors for the treatment of…”
Get full text
Journal Article -
11
Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1
Published in Bioorganic & medicinal chemistry letters (01-12-2010)“…Microsomal prostaglandin E(2) synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening…”
Get full text
Journal Article -
12
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases
Published in Bioorganic & medicinal chemistry letters (01-01-2011)“…In this manuscript we wish to report the discovery of MK-7246 (4), a potent and selective CRTH2 (DP2) antagonist. SAR studies leading to MK-7246 along with two…”
Get full text
Journal Article -
13
Trisubstituted ureas as potent and selective mPGES-1 inhibitors
Published in Bioorganic & medicinal chemistry letters (01-03-2011)“…A novel series of trisubstituted ureas has been identified as potent and selective mPGES-1 inhibitors. These compounds are selective over other prostanoid…”
Get full text
Journal Article -
14
Optimization and structure–activity relationship of a series of 1-phenyl-1,8-naphthyridin-4-one-3-carboxamides: Identification of MK-0873, a potent and effective PDE4 inhibitor
Published in Bioorganic & medicinal chemistry (15-10-2008)“…Discovery of the potent and orally active PDE4 inhibitors 18 and 20 (PDE4A IC 50 = 6 and 7 nM; HWB IC 50 = 0.12 and 0.18 μM) is reported. A SAR study of a…”
Get full text
Journal Article -
15
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP₄ receptor
Published in Bioorganic & medicinal chemistry letters (01-02-2011)“…Two new series of EP₄ antagonists based on naphthalene/quinoline scaffolds have been identified as part of our on-going efforts to develop treatments for…”
Get full text
Journal Article -
16
The C3a receptor antagonist SB 290157 has agonist activity
Published in Immunology Letters (15-09-2005)“…The anaphylatoxin C3a is an important immune regulator with a number of distinct functions in both innate and adaptive immunity. Many of these roles have been…”
Get full text
Journal Article -
17
-
18
Observation of .alpha.-silyl carbanions in the metalation of 3,4,6-tri-O-(tert-butyldimethylsilyl)-D-glucal
Published in Journal of organic chemistry (01-03-1991)Get full text
Journal Article -
19
Catalytic Inactivation of Protein Tyrosine Phosphatase CD45 and Protein Tyrosine Phosphatase 1B by Polyaromatic Quinones
Published in Biochemistry (Easton) (13-04-2004)“…Polyaromatic quinones, such as the environmental pollutants 9,10-phenanthrenediones, elicit a wide range of responses including growth inhibition, immune…”
Get full text
Journal Article -
20